NLS PHARMACEUTICS LTD's ticker is NLSP and the CUSIP is H57830103. A total of 6 filers reported holding NLS PHARMACEUTICS LTD in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $1,246,552 | +19.3% | 5,747,126 | 0.0% | 0.04% | +20.7% |
| Q1 2024 | $1,044,828 | -69.2% | 5,747,126 | 0.0% | 0.03% | -65.9% |
| Q4 2023 | $3,390,230 | -14.6% | 5,747,126 | 0.0% | 0.08% | -20.6% |
| Q3 2023 | $3,970,689 | -37.2% | 5,747,126 | 0.0% | 0.11% | -39.2% |
| Q2 2023 | $6,321,839 | -27.2% | 5,747,126 | 0.0% | 0.18% | -44.5% |
| Q1 2023 | $8,678,160 | +17.1% | 5,747,126 | 0.0% | 0.32% | +1.3% |
| Q4 2022 | $7,413,793 | – | 5,747,126 | – | 0.31% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tower Research Capital LLC (TRC) | 36,525 | $148,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| Clearstead Advisors, LLC | 300 | $1,000 | 0.00% |
| MILLENNIUM MANAGEMENT LLC | 33,213 | $134,000 | 0.00% |